INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 81 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $41,279,000 | 3.63% |
| NORTHPOINTE CAPITAL LLC | 528,739 | $1,433,000 | 0.21% |
| Opaleye Management Inc. | 275,000 | $745,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 364,401 | $988,000 | 0.12% |
| EcoR1 Capital, LLC | 462,068 | $1,252,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 990,748 | $2,685,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 284,354 | $771,000 | 0.04% |
| Fosun International Ltd | 358,859 | $879,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 97,630 | $200,000 | 0.04% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $81,000 | 0.04% |